ALIM Price Targets and Analyst Ratings NASDAQ:ALIM
ALIM Forecast. What You Should Know.
ALIM Historical Ratings and Targets
About Alimera Sciences
Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affectin... ALIM Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.